Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125543331 | 12554333 | 1 | I | 20160206 | 20160713 | 20160713 | PER | US-ROCHE-1708281 | ROCHE | 0.00 | F | Y | 0.00000 | 20160713 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125543331 | 12554333 | 1 | PS | PERJETA | PERTUZUMAB | 1 | Unknown | U | 125409 | ||||||||||
125543331 | 12554333 | 2 | SS | Trastuzumab | TRASTUZUMAB | 1 | Unknown | U | 103792 | ||||||||||
125543331 | 12554333 | 3 | C | TAXOTERE | DOCETAXEL | 1 | Unknown | 0 | |||||||||||
125543331 | 12554333 | 4 | C | CARBOPLATIN. | CARBOPLATIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125543331 | 12554333 | 1 | HER-2 positive breast cancer |
125543331 | 12554333 | 2 | HER-2 positive breast cancer |
125543331 | 12554333 | 3 | HER-2 positive breast cancer |
125543331 | 12554333 | 4 | HER-2 positive breast cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125543331 | 12554333 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125543331 | 12554333 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |